Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination
(2008) In Virology 375(2). p.315-320- Abstract
- In AIDS vaccine development the pendulum has swung towards a renewed emphasis on the potential role for neutralizing antibodies in a successful global vaccine. It is recognized that vaccine-induced antibody performance, as assessed in the available neutralization assays, may well serve as a "gatekeeper" for HIV-1 subunit vaccine prioritization and advancement. As a result, development of a standardized platform for reproducible measurement of neutralizing antibodies has received considerable attention. Here we review current advancements in our knowledge of the performance of different types of antibodies in a traditional primary cell neutralization assay and the newer, more standardized TZM-bl reporter cell line assay. In light of... (More)
- In AIDS vaccine development the pendulum has swung towards a renewed emphasis on the potential role for neutralizing antibodies in a successful global vaccine. It is recognized that vaccine-induced antibody performance, as assessed in the available neutralization assays, may well serve as a "gatekeeper" for HIV-1 subunit vaccine prioritization and advancement. As a result, development of a standardized platform for reproducible measurement of neutralizing antibodies has received considerable attention. Here we review current advancements in our knowledge of the performance of different types of antibodies in a traditional primary cell neutralization assay and the newer, more standardized TZM-bl reporter cell line assay. In light of recently revealed differences (see accompanying article) in the results obtained in these two neutralization formats, parallel evaluation with both platforms should be contemplated as an interim solution until a better understanding of immune correlates of protection is achieved. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1201927
- author
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- vaccine immune assessment, standardization, pseudovirus, assays, neutralization, human immunodeficiency virus type I (HIV-1), antibodies
- in
- Virology
- volume
- 375
- issue
- 2
- pages
- 315 - 320
- publisher
- Elsevier
- external identifiers
-
- wos:000256106200001
- scopus:43249120426
- pmid:18367229
- ISSN
- 1096-0341
- DOI
- 10.1016/j.virol.2008.02.007
- language
- English
- LU publication?
- yes
- id
- 736d286c-42d8-475c-a593-806e48b56e80 (old id 1201927)
- date added to LUP
- 2016-04-01 13:10:27
- date last changed
- 2022-02-19 03:23:55
@article{736d286c-42d8-475c-a593-806e48b56e80, abstract = {{In AIDS vaccine development the pendulum has swung towards a renewed emphasis on the potential role for neutralizing antibodies in a successful global vaccine. It is recognized that vaccine-induced antibody performance, as assessed in the available neutralization assays, may well serve as a "gatekeeper" for HIV-1 subunit vaccine prioritization and advancement. As a result, development of a standardized platform for reproducible measurement of neutralizing antibodies has received considerable attention. Here we review current advancements in our knowledge of the performance of different types of antibodies in a traditional primary cell neutralization assay and the newer, more standardized TZM-bl reporter cell line assay. In light of recently revealed differences (see accompanying article) in the results obtained in these two neutralization formats, parallel evaluation with both platforms should be contemplated as an interim solution until a better understanding of immune correlates of protection is achieved.}}, author = {{Polonis, Victoria R and Brown, Bruce K and Borges, Andrew Rosa and Zolla-Pazner, Susan and Dimitrov, Dimiter S and Zhang, Mei-Yun and Barnett, Susan W and Ruprecht, Ruth M and Scarlatti, Gabriella and Fenyö, Eva Maria and Montefiori, David C and McCutchan, Francine E and Michael, Nelson L}}, issn = {{1096-0341}}, keywords = {{vaccine immune assessment; standardization; pseudovirus; assays; neutralization; human immunodeficiency virus type I (HIV-1); antibodies}}, language = {{eng}}, number = {{2}}, pages = {{315--320}}, publisher = {{Elsevier}}, series = {{Virology}}, title = {{Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination}}, url = {{http://dx.doi.org/10.1016/j.virol.2008.02.007}}, doi = {{10.1016/j.virol.2008.02.007}}, volume = {{375}}, year = {{2008}}, }